教授挨拶(業績)

トップページ > 教授挨拶 > 教授挨拶(業績)

2019年

No./タイトル/掲載誌
646. Goto A, Matsuhashi N, Takahashi T, Sato Y, Hirata S, Tanahashi T, Matsui S, Imai H, Tanaka Y, Yamaguchi K, Yoshida K: Single-incision laparoscopic ileocecal resection in a 10-year-old child with appendiceal neuroendocrine tumor. World Journal of Surgical Oncology 17, Article number: 197,2019
645. Fukada M, Matsuhashi N, Takahashi T, Imai H, Tanaka Y, Yamaguchi K, Yoshida K: Risk and early predictive factors of anastomotic leakage in laparoscopic low anterior resection for rectal cancer. World Journal of Surgical Oncology 17(1):178,2019
644. Matsuhashi N, Takahashi T, Fujii H, Suetsugu T, Fukada M, Iwata Y, Tokumaru Y, Imai T, Mori R, Tanahashi T, Matsui S, Imai H, Tanaka Y, Yamaguchi K, Futamura M, Yoshida K: Combination chemotherapy with TAS‑102 plus bevacizumab in salvage‑line treatment of metastatic colorectal cancer: A single‑center, retrospective study examining the prognostic value of the modified Glasgow Prognostic Score in salvage‑line therapy of metastatic colorectal cancer. Molecular and Clinical Oncology 11(4):390-396, DOI: 10.3892/mco.2019.1899,2019
643. Iwata Y, Matsuhashi N, Takahashi T, Suetsugu T, Fukada M, Yasufuku I, Imai T, Tanahashi T, Matsui S, Imai H, Tanaka Y, Yamaguchi K, Yoshida K: Diabetic ketoacidosis caused by fulminant type 1 diabetes during adjuvant chemotherapy for colon cancer: A case report. Molecular and Clinical Oncology 11(2) 189-191, 2019
642. Tachi M, Okada H, Matsuhashi N, Takemura G, Suzuki K, Fukuda H, Niwa A, Tanaka T, Mori H, Hara A, Yoshida K, Ogura S, Tomita H: Human Colorectal Infrastructure Constructed by the Glycocalyx. Journal of Clinical Medicine 8, 1270, 2019
641. Tanaka Y, Ueno T, Yoshida N, Akutsu Y, Takeuchi H, Baba H, Matsubara H, Kitagawa Y, Yoshida K.: Is Oral Mucositis Occurring During Chemotherapy for Esophageal Cancer Patients Correctly Judged? EPOC Observational Cohort Study. Anticancer Research 39(8): 4441-4448, 2019
640. Imai T, Tanaka Y, Adachi T, Suetsugu T, Fukada M, Tanahashi T, Matsui S, Imai H, Kato T, Matsuhashi N, Takahashi T, Yamaguchi K, Shiroko T, Yoshida K: Theracoscopic subtotal esophagectomy via a right thoracic cavity approach to treat an intractable fistula after 20 months from onset of an idiopathic esophageal rupture: A case report. Asian Journal of Endoscopic Surgery, 2019 doi: 10.1111/ases.12736.
639. Futamura M, Nakada T, Kawaguchi Y, Nawa M, Takeuchi M, Ishihara K, Nagao Y, Morimitsu K, Ogiso A, Matsuki T, Kato J, Asano Y, Tokumaru Y, Shimokawa T, Yoshida K: Examination of the Efficacy of Fulvestrant 500 mg Targeting Estrogen Receptor-Positive Postmenopausal Metastatic Breast Cancer: Prospective Observational Study (PerSeUS BC03 Study). Clinics in Oncology 2019 Volume 4: Article 1633, 2019
638. Tokumaru Y, Matsuhashi N, Takahashi T, Tanahashi T, Matsui S, Imai H, Tanaka Y, Yamaguchi K, Yoshida K: Efficacy of combination therapy with zoledronic acid and cetuximab for unresectable rectal cancer with bone metastases: A case report. Molecular and Clinical Oncology 10(6) 571-574, 2019
637. Mori R, Yoshida K, Futamura M, Suetsugu T, Shizu K, Tanahashi T, Tanaka Y, Matsuhashi N, Yamaguchi K: The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells. Gastric Cancer 22(3):497-505, 2019 DOI:10.1007/s10120-018-0881-3
636. Tanaka Y, Yamada A, Hirata S, Tanaka H, Sakuratani T, Matsuhashi N, Yamaguchi K, Shimokawa T, Yoshida K: Efficacy and Safety of enoxaparin for Prophylaxis of Postoperative Venous Thromboembolism After Esophagectomy: A Single-center Prospective Randomized Controlled Phase II Study. Anticancer Research 39(5):2615-2625, 2019
635. Tokumaru Y, Tajirika T, Sugito N, Kuranaga Y, Shinohara H, Tsujino T, Matsuhashi N, Futamura M, Akao Y, Yoshida K: Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase. International Journal of Molecular Sciences 20(7): 1697, 2019
634. Asano Y, Takeuchi T, Okubo H, Saigo C, Kito Y, Iwata Y, Futamura M, Yoshida K: Nuclear localization of LDL receptor-related protein 1B in mammary gland carcinogenesis. Journal of Molecular Medicine 97(2): 257-268, 2019
633. Tanahashi T, Yoshida K, Yamaguchi K, Okumura N, Takeno A, Fujitani K, Fukushima N, Takiguchi N, Nishida Y, Boku N, Yoshikawa T, Terashima M: Questionnaire survey on adjuvant chemotherapy for elderly patients after gastrectomy indicates their vulnelabilities. Gastric Cancer 22(1):130-137, 2019
632. Matsuhashi N, Takahashi T, Fujii H, Iihara H, Suetsugu T, Iwata Y, Tajima JY, Imai T, Mori R, Tanahashi T, Matsui S, Imai H, Tanaka Y, Yamaguchi K, Yoshida K: Preventive Effect and Safety of Pregabalin for FOLFOX-Related Peripheral Neurotoxicity in Patients with Advanced and Recurrent Colorectal Cancer: The Perpetual Study Estimated by United Sections in Gifu for Colorectal Cancer (Perseus CRC-01 Study). Clinics of Oncology 1(6):1-6, 2019
631. Trotta L, Kabeya Y, Buyse M, Doffagne E, Venet D, Desmet L, Burzykowski T, Tsuburaya A, Yoshida K, Miyashita Y, Morita S, Sakamoto J, Praveen P, Oba K: Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring. Clinical Trials 16(5):512-522,2019
630. Haga Y, Miyata H, Tsuburaya A, Gotoh M, Yoshida K, Konno H, Seto Y, Fujiwara Y, Baba H: Development and Validation of Grade-Based Prediction Models for Postoperative Morbidity in Gastric Cancer Resection using a Japanese web-based nationwide registry. Annals of Gastroenterological Surgery 3:544-551, 2019
629. Kurokawa Y, Takeuchi H, Doki Y, Mine S, Terashima M, Yasuda T, Yoshida K, Daiko H, Sakuramoto S, Yoshikawa T, Kunisaki C, Seto Y, Tamura S, Shimokawa T, Sano T, Kitagawa Y: Mapping of lymph node metastasis from esophagogastric junction tumours: a prospective nationwide multi-centre study. Annals of Surgery, DOI: 10.1097/SLA.0000000000003499 Epub ahead of print
628. Yoshikawa T, Muro K, Shitara K, Oh DY, Kang YK, Chung HC, Kudo T, Chin K, Kadowaki S, Hamamoto Y, Hironaka S, Yoshida K, Yen CJ, Omuro Y, Bai LY, Maeda K, Ozeki A, Yoshikawa R, Kitagawa Y: Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia The Phase 2 RAINSTORM Randomized Clinical Trial JAMA Network Open 2(8):e198243, 2019 doi:10.1001/jamanetworkopen.2019.8243
627. Yamada Y, Fujii H, Ohata K, Kato-Hayashi H, Watanabe D, Ishihara T, Uemura S, Iwashita T, Imai H, Matsuhashi N, Takahashi T, Sugiyama T, Shimizu M, Yoshida K, Suzuki A: High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapy. Medical Oncology 36(7):63, 2019
626. Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M: Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial. Journal of Clinical Oncology 37(15):1296-1304, 2019
625. Yoshikawa T, Terashima M, Mizusawa J, Nunobe S, Nishida Y, Yamada T, Kaji M, Fukushima N, Hato S, Choda Y, Yabusaki H, Yoshida K, Ito S, Takeno A, Yasuda T, Kawachi Y, Katayama H, Fukuda H, Boku N, Sano T, Sasako M: Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trial. Lancet Gastroenterology & Hepatology 4(3):208-216, 2019
624. Iihara H, Fujii H, Yoshimi C, Kobayashi R, Matsuhashi N, Takahashi T, Yoshida K, Suzuki A: Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome. Cancer Chemotherapy and Pharmacology 83(3):393-398, 2019
623. Kato K, Satoh T, Muro K, Yoshikawa T, Tamura T, Hamamoto Y, Chin K, Minashi K, Tsuda M, Yamaguchi K, Machida N, Esaki T, Goto M, Komatsu Y, Eguchi Nakajima T, Sugimoto N, Yoshida K, Oki E, Nishina T, Tsuji A, Fujii H, Kunieda K, Saitoh S, Omuro Y, Azuma M, Iwamoto Y, Taku K, Fushida S, Chen LT, Kang YK, Boku N: A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2). Gastric Cancer 22(2):344-354, 2019
622. Nakamura Y, Yamanaka T, Chin K, Cho H, Katai H, Terashima M, Misawa K, Hirao M, Yoshida K, Oki E, Sasako M, Emi Y, Bando H, Kawashima Y, Fukunaga T, Gotoh M, Ishibashi T, Shitara K: Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy. Ann Surg Oncol 26(2):465-472, 2019
621. Maeda H, Nagata N, Nagasaka T, Oba K, Mishima H, Kato T, Yoshida K, Muro K, Sakamoto J: A multicenter single‑arm Phase II clinical trial of second‑line FOLFIRI plus panitumumab after first‑line treatment with FOLFOX plus panitumumab for initial RAS wild‑type colorectal cancer with evaluation of circulating tumor DNA: A protocol study. Oncology letters 17(2):1980-1985, 2019
620. Fujii H, Yamada Y, Watanabe D, Matsuhashi N, Takahashi T, Yoshida K, Suzuki A: Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer. Cancer Chemotherapy and Pharmacology 83(1):123-129, 2019
619. Kodera Y, Yoshida K, Kumamaru H, Kakeji Y, Hiki N, Etoh T, Honda M, Miyata H, Yamashita Y, Seto Y, Kitano S, Konno H: Introducing laparoscopic total gastrectomy for gastric cancer in general practice: a retrospective cohort study based on a nationwide registry database in Japan. Gastric Cancer 22(1):202-213, 2019
618. Iwatsuki M, Yamamoto H, Miyata H, Kakeji Y, Yoshida K, Konno H, Seto Y, Baba H: Effect of hospital and surgeon volume on postoperative outcomes after distal gastrectomy for gastric cancer based on data from 145,523 Japanese patients collected from a nationwide web-based data entry system. Gastric Cancer 22(1):190-201, 2019
617. 田中善宏、吉田和弘、末次智成、今井健晴、安福至、棚橋利行、山口和也: 症例から考える エキスパートの治療法 実際の処置と注意点について. 胃がんperspective 10(2), 41, 2019
616. 松橋延壽、高橋孝夫、吉田和弘: レゴラフェニブの使用経験-当院経口薬剤における多職種連携によるCDTM-. 大腸癌に対するレゴラフェニブ治療
615. 深田真宏、田中善宏、今井健晴、松井聡、今井寿、松橋延壽、高橋孝夫、二村学、山口和也、吉田和弘: 進行食道癌に対するdocetaxel・5-fluorouracil 併用術前補助化学放射線療法の有効性と安全性についての検討. 日本消化器外科学会雑誌 52(12):753-763,2019
614. 近石和花菜、松橋延壽、高橋孝夫、田中善宏、山口和也、吉田和弘: 肺癌に対する免疫チェックポイント阻害薬使用による直腸S状部穿孔の1例. 日本臨床外科学会雑誌 80(9):123-128, 2019
613. 安福至、吉田和弘、山口和也、棚橋利行、今井健晴、末次智成: 胃癌治療の現状と課題(5)開腹手術. 臨牀消化器内科 34(11):1384-1389, 2019
612. 深田真宏、松橋延壽、高橋孝夫、棚橋利行、松井聡、今井寿、田中善宏、二村学、山口和也、吉田和弘: 経直腸EUS-FNAと血管造影検査が治療に有用であった巨大小腸 gastrointestinal stromal tumor の1例. 日本消化器外科学会雑誌 52(8):475-483, 2019
611. 松橋延壽、吉田和弘: Conversion surgeryの考え方─Precision medicineからPrecision surgeryへの幕開け. 別冊・医学のあゆみ:95-102 ,2019
610. 末次智成、松橋延壽、高橋孝夫、棚橋利行、松井聡、今井寿、田中善宏、山口和也、宮崎龍彦、吉田和弘: ニボルマブの使用によりリウマチ性多発筋痛症を発症した直腸肛門部悪性黒色腫術後再発の1例. 日本消化器外科学会雑誌 52(6):327-335, 2019
609. 今井健晴、吉田和弘、田中善宏、末次智成、深田真宏、山口和也: 特集 食道癌手術の最前線-合併症ゼロを目指した私の秘訣 縫合不全ゼロを目指す亜全胃を用いた再建術. 手術 73(6) :877-884, 2019
608. 安福至、吉田和弘、山口和也、棚橋利行、今井健晴、末次智成: 腹腔鏡下幽門側胃切除術における助手・スコピストの役割. 手術 73(5):669-680, 2019
607. 松橋延壽、吉田和弘: [ユーザ使用体験]GOD VISION を使用して. 映像情報メディカル 51(4):20-21, 2019
606. 水谷千佳、松橋延壽、高橋孝夫、高野仁、山口和也、吉田和弘: 経会陰アプローチで切除した下部直腸GISTの1例. 日本臨床外科学会雑誌 80(2):379-385, 2019
605. 松橋延壽、今井寿、吉田和弘: 連載:外科医を育てる!(第19回) 岐阜大学腫瘍外科の若手外科医の勧誘と指導法の取り組み. 外科 81(1):64-67, 2019
604. 吉田和弘: TS-1の特徴と胃がん治療における役割 第4回胃がん周術期におけるTS-1の位置づけ. 胃癌 perspective 10(2):76-81,2019
603. 吉田和弘、田中善宏: 岐阜大学医学部附属病院 Report20 ‛がん'に2人に1人がなる時代-私たちは何をすべきか-. 経済月報 Economic Monthly Report2019 765(5):22-23,2019